After you begin therapy, most patients recheck labs at 6 weeks, 12 weeks, and then every 6 months if everything is stable
The pattern most often described now has two phases: Loading / tolerance phase: roughly 50 mcg 1 unit on a U-100 insulin syringe at the standard 10 mg / 2 mL reconstitution subcutaneously once daily for about 7 days in a row, or until noticeable color begins to appear
Many physicians and researchers have become interested in the potential cardiovascular advantages of GLP-1 and GLP-1-based medication since the discovery of GLP-1Rs on cardiomyocytes
Inspect both thighs visually before each injection and avoid any areas that feel firm, lumpy, or appear discolored
Do not start other medications while on semaglutide without checking with your doctor
By using these new approaches and medications, doctors can help patients continue their heart failure treatment safely, improving their health outcomes and reducing the risk of serious complications
